Product Images Fluticasone Propionate Diskus
View Photos of Packaging, Labels & Appearance
- Fluticasone propionate chemical structure - fluticasone propionate diskus spl graphic 01
- Figure 1 - fluticasone propionate diskus spl graphic 02
- Figure 2 - fluticasone propionate diskus spl graphic 03
- Figure 3 - fluticasone propionate diskus spl graphic 04
- Figure 4 - fluticasone propionate diskus spl graphic 05
- Figure A - fluticasone propionate diskus spl graphic 06
- Figure B - fluticasone propionate diskus spl graphic 07
- Figure C - fluticasone propionate diskus spl graphic 08
- Figure D - fluticasone propionate diskus spl graphic 09
- Figure E - fluticasone propionate diskus spl graphic 10
- Figure F - fluticasone propionate diskus spl graphic 11
- Figure G - fluticasone propionate diskus spl graphic 12
- Figure H - fluticasone propionate diskus spl graphic 13
- Label Image - lbl500907076
Product Label Images
The following 14 images provide visual information about the product associated with Fluticasone Propionate Diskus NDC 50090-7076 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - fluticasone propionate diskus spl graphic 02
This text appears to be a description of a study or evaluation involving the drug Fluticasone Propionate DISKUS. The drug is administered twice daily at a dosage of 100 mcg. The study measures the change in Forced Expiratory Volume (FEV) from the baseline measurement. One group receives Fluticasone Propionate DISKUS while another group receives a placebo. The text includes a progress timeline with measurements at various time points. Overall, the description likely pertains to a study evaluating the efficacy of Fluticasone Propionate DISKUS in improving FEV.*
Figure 2 - fluticasone propionate diskus spl graphic 03
This text appears to be a description of a medical study or evaluation involving the use of Fluticasone Propionate DISKUS at a dosage of 100 mcg twice daily. It also mentions a placebo group. The text includes data on the baseline forced expiratory volume and indicates a percentage change from baseline, but the specific values are not readable. The text ends with a mention of an endpoint.*
Figure A - fluticasone propionate diskus spl graphic 06
The text provided is a list of parts or components of an object. It appears to be describing the various elements of an item, possibly a device or tool. Unfortunately, without further context or clarification, it is not possible to determine the specific object or provide a more detailed description.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.